Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medmen Enterprises Inc (OP: MMNFF )

N/A UNCHANGED
Last Price Updated: 2:16 PM EST, Jan 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medmen Enterprises Inc

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Should You Buy The Dip In Tilray?
Tilray’s acquisition strategy could drive its long-term growth. However, the company’s shares have fallen in price significantly over the past six months. Furthermore, considering Tilray’s weak bottom... 
Via Talk Markets
Cannabis Movers & Shakers: MedMen, Green Check Verified, Beatrice Society, LOOP/POOL
MedMen Enterprises Appoints Michael Serruya As Chairman & Interim CEO Cannabis retailer MedMen Enterprises Inc. (C... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Cleared By Jury In Wrongful Termination Suit Brought By Former CFO James Parker
Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Prevails in Lawsuit Against Former CFO James Parker
From MedMen Enterprises Inc.
Via Business Wire
Earnings: MedMen Q1 Revenue Increases 13% to $39.8M
MedMen Enterprises Inc. CSE: MMEN) (OTCQX: 
Via Benzinga
Tilray Remains a Solid Pot Play
The market's still skeptical about TLRY stock and other cannabis names, but this factor may work in your favor. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
MedMen Announces Michael Serruya as Chairman and Interim CEO
From MedMen Enterprises Inc.
Via Business Wire
Tilray Received Some Good News, But Is It Enough?
TLRY stock represents one of the bigger Canadian cannabis operations -- and it has done well. But is that enough reason to buy Tilray now? 
Via InvestorPlace
Topics Cannabis Electric Vehicles
Exposures Cannabis Electric Vehicles
Tilray Has More Bad News Harshing Their Mellow
But despite the near constant bad news for the cannabis industry, aggressive investors should still buy TLRY stock under $11. 
Via InvestorPlace
Topics Cannabis Economy
Exposures Cannabis Economy
Cannabis Movers & Shakers: Aurora Cannabis, Dama Financial, Neptune Wellness, Avicanna
Dama Financial Appoints Industry Veteran Ed Labry As Executive Chairman Of Board Dama Financial, a provider of access ... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Some Cannabis Companies Are Prepping for a Possible Next Wave of Legislative Change
Photo by Shelby Ireland on 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Tyson 2.0, Akanda, Shryne Group, MedMen
Akanda Taps Dr. Aslihan Akkar-Schenkl As President Akanda Corp., which recently 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
Mind Medicine Appoints Maria A. Oquendo To Scientific Advisory Board Psychedelic-focused biotech company Mind Medicine Inc. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Still On Track To Be Premier Cannabis Retailer Despite Litigation Hurdles, Analyst's Take On Q1 Earnings
Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Earnings Scorecard $ACB $VFF — Cannabis Daily November 10, 2021
Start The Day With The Best Daily Pre-Market Overview Of The Cannabis Space Today On Cannabis Daily, host 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Wars: Tilray Vs. Aurora Cannabis
Weed stocks have been trading higher in the last couple of days with AdvisorShares Pure Cannabis ETF (ARCA: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Reports 13% Year-over-Year Quarterly Revenue Growth and Fifth Consecutive Quarter of Positive Retail Adjusted EBITDA
From MedMen Enterprises
Via Business Wire
MedMen Announces Board Changes
From MedMen Enterprises Inc.
Via Business Wire
Video: Overcoming The Biggest Hurdle In Legal Cannabis, Banking
Benzinga’s 
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's In The Cards For Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season
Via Talk Markets
What's In The Cards For Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season
With earnings season underway, investors should be closely watching top cannabis stocks over the coming weeks. Some of t... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Acreage, MedMen, Halo Collective, Fire & Flower, Cronos Group, Perfect Union
Halo Collective Hires John Ford As SVP Of Retail Ahead Of Opening Its First California Store Halo Collective Inc. (NEO... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Stocks Underperform, Policy Moves, Earnings, Pitbull, Lil Kim, Justin Bieber, Martha Stewart And More
Below is a recap of the main news related to the cannabis industry and markets for the week of October 25, 2021. Contents Markets Policy & Social Equity M&A... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen To Announce First Quarter Fiscal 2022 Financial Results on November 9, 2021
From MedMen Enterprises
Via Business Wire
Curaleaf, Columbia Care, PharmaCann Begin Whole Flower Cannabis Sales In New York
New York's long-awaited adult-use cannabis program is live, almost. As it evolves, big names in the space are eager to take their place al... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Urban-Gro, MediPharm Labs, RWB, Isracann Biosciences, MedMen
Former Crop One and Sensei Ag CEO Sonia Lo Joins Urban-Gro’s Board Of Directors Urban-gro, Inc. (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Appoints New COO: Roz Lipsey Takes The Reins
Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MedMen Announces Promotion of Roz Lipsey to Chief Operating Officer
From MedMen Enterprises Inc.
Via Business Wire
MedMen Announces Re-Opening of Tallahassee, Florida Location
From MedMen Enterprises Inc.
Via Business Wire
Tilray's Q1 Revenue Grows 43% To $168M, Achieves 10th Consecutive Quarter Of Positive Adjusted EBITDA
Canadian cannabis giant Tilray, Inc. (NASDAQ:TLRY) (TSX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.